Blume Capital Management’s Exact Sciences EXAS Stock Holding History

Blume Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-100	Closed	-$6.91K	–	320
2024 Q1	$6.91K	Sell	100 -110	-52%	-$6.96K	﹤0.01%	265
2023 Q4	$15.5K	Hold	210	–	–	﹤0.01%	228
2023 Q3	$14.3K	Hold	210	–	–	﹤0.01%	231
2023 Q2	$19.7K	Hold	210	–	–	0.01%	216
2023 Q1	$14.2K	Hold	210	–	–	﹤0.01%	226
2022 Q4	$10.4K	Hold	210	–	–	﹤0.01%	247
2022 Q3	$7K	Hold	210	–	–	﹤0.01%	258
2022 Q2	$8K	Hold	210	–	–	﹤0.01%	258
2022 Q1	$15K	Hold	210	–	–	﹤0.01%	233
2021 Q4	$16K	Hold	210	–	–	0.01%	229
2021 Q3	$20K	Hold	210	–	–	0.01%	230
2021 Q2	$26K	Hold	210	–	–	0.01%	204
2021 Q1	$28K	Hold	210	–	–	0.01%	186
2020 Q4	$28K	Hold	210	–	–	0.01%	144
2020 Q3	$21K	Hold	210	–	–	0.01%	150
2020 Q2	$18K	Hold	210	–	–	0.01%	149
2020 Q1	$12K	Hold	210	–	–	0.01%	169
2019 Q4	$19K	Hold	210	–	–	0.01%	161
2019 Q3	$18K	Buy	+210	New	+$23.9K	0.01%	163
2019 Q2	–	Sell	-210	Closed	-$18K	–	221
2019 Q1	$18K	Buy	+210	New	+$17.9K	0.01%	165

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Blume Capital Management's EXAS Position: Q2 2024 in Review

Blume Capital Management sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 100 shares — an estimated $6.91K sold.

Blume Capital Management first reported a position in EXAS in Q1 2019 and held it in 20 quarters. The position peaked at $28K in Q1 2021. 543 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

Blume Capital Management reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
Blume Capital Management sold 100 Exact Sciences shares in Q2 2024, an estimated $6.91K.
Blume Capital Management first reported a position in Exact Sciences in Q1 2019 and held it in 20 quarters.
Blume Capital Management's Exact Sciences position peaked at $28K in Q1 2021.
543 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Blume Capital Management's 13F filing for Q2 2024, filed 5 Aug 2024.